When developing countries band together, lifesaving drugs become cheaper and easier to buy − with trade-offs

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often neither available nor affordable in these nations, even decades after the drugs entered…

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science

Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical…

‘From Magic Mushrooms to Big Pharma’ – a college course explores nature’s medicine cabinet and different ways of healing

Uncommon Courses is an occasional series from The Conversation U.S. highlighting unconventional approaches to teaching. Title of course: “From Magic Mushrooms to Big Pharma” What prompted the idea for the…